Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 16, 2026
TZA ETF Advances +21% as Small-Cap Weakness Persists

TZA ETF Advances +21% as Small-Cap Weakness Persists

Key Takeaways

  • TZA, a leveraged inverse ETF, has climbed roughly 21% over the last 30 days.
  • The advance reflects a decline in the Russell 2000 small-cap index, to which TZA provides -3x daily inverse exposure.
  • Over the trailing quarter, the fund is up a more modest single-digit percentage after a volatile, range-bound stretch.
  • Daily-reset leverage means returns compound over time and can diverge sharply from -3x the index across longer horizons.
  • Primary drivers center on small-cap sensitivity to interest rates, credit conditions, and the economic growth outlook.

Understanding TZA’s Exposure to Small-Cap Equities

TZA seeks daily investment results, before fees and expenses, equal to 300% of the inverse of the daily performance of the Russell 2000 Index. The Russell 2000 tracks roughly 2,000 small-capitalization US companies drawn from the Russell 3000, representing about 10% of that broader index’s total market capitalization.

The fund does not invest directly in the underlying equities. It is a passively managed, synthetically replicated leveraged inverse ETF that gains exposure primarily through index swap agreements, futures, and short positions, with the remainder of assets held in money market instruments. Its net expense ratio is 0.99%.

Because TZA shorts the small-cap universe, its sector exposure is the inverse of the Russell 2000’s composition. Industrials, Health Care, Financials, and Information Technology are the index’s largest weightings, so weakness in those economically sensitive segments—particularly rate- and credit-sensitive regional banks and cyclical industrial names—tends to lift TZA. The index’s largest single constituents include Bloom Energy, Coeur Mining, and Fabrinet, each representing less than about 1% of the benchmark. This inverse, three-times-leveraged structure explains why modest small-cap declines translate into outsized gains for the fund. I also checked comparable inverse products using Tickeron’s AI Screener to see how TZA stacks up against peers in the leveraged ETF space.

Price Performance: Last 30 Days Versus the Quarter

Over the last 30 days, TZA has advanced approximately 21%, rising from a closing level near $36.73 to about $44.28. The move was not entirely linear: the fund gained steadily off a mid-August low as the underlying small-cap benchmark weakened, with the pace accelerating into September.

The trailing quarter tells a more muted story. Three months ago the fund closed near $41.70, putting the quarterly change at roughly 6%. That modest net gain masks meaningful volatility—TZA first declined through the summer as small caps rallied, bottoming in the mid-$36 range in mid-August, before reversing sharply higher. In short, the recent 30-day rally represents the most concentrated leg of an otherwise choppy, range-bound quarter.

What Drove the Recent 30-Day Advance

As a -3x inverse vehicle, TZA’s direction is almost entirely determined by the opposite of the Russell 2000’s daily move, amplified threefold. The recent advance therefore indicates that small-cap equities came under selling pressure during the period.

Small caps are disproportionately sensitive to the trajectory of interest rates, the availability of credit, and the domestic growth outlook. Their heavier weightings in financials (including regional banks), industrials, and consumer cyclicals make them more exposed to shifts in borrowing costs and economic sentiment than large-cap benchmarks. When expectations around monetary policy or growth deteriorate, the Russell 2000 often underperforms—and TZA rises in response.

Because the fund’s returns compound daily, the roughly 21% gain reflects the cumulative effect of multiple down days in the benchmark rather than a single event. The magnitude of the move is a direct function of the three-times leverage, which magnifies even a mid-single-digit decline in the underlying index into a double-digit gain for TZA.

Quarterly Performance and Broader Context

The broader three-month trend has been less directional. Through much of the quarter, small caps demonstrated relative resilience, which pressured TZA lower; the fund declined from roughly $42 in mid-June to the mid-$36 area by mid-August. That earlier phase reflected a period in which investors favored risk assets and small-cap names staged a rebound.

The reversal in the final weeks of the quarter shifted the fund back into positive territory. Renewed caution around the macroeconomic backdrop—encompassing interest-rate expectations, inflation readings, and credit conditions—weighed on the economically sensitive small-cap cohort. Institutional flows into inverse and hedged products tend to rise during such periods, supporting leveraged short vehicles like TZA.

Net, the quarter illustrates the fund’s defining characteristic: it is a short-term tactical tool whose longer-horizon return is shaped by daily compounding and the path of the underlying index, not simply by where the index starts and ends.

Key Factors to Monitor Going Forward

Going forward, the most important variables for TZA will be those that drive the Russell 2000. Investors should monitor the path of interest rates and central-bank guidance, as small-cap valuations and financing conditions are highly sensitive to borrowing costs. Inflation trends and their implications for monetary policy will remain central, alongside credit availability for the regional banks that populate the index.

Economic growth indicators—employment, consumer spending, and manufacturing activity—will also shape sentiment toward cyclical small caps. Sector-specific developments in financials, industrials, and health care, the index’s largest weightings, could produce outsized moves given the fund’s leverage. Capital flows into and out of risk assets, as well as demand for hedged and inverse products, may further influence short-term pricing.

Finally, investors should keep in mind the structural risks of daily-reset leveraged and inverse ETFs, including compounding effects, volatility drag, and the potential for returns to diverge materially from -3x the index over periods longer than one day. These are trading vehicles, not long-term investments.

AI-Powered Screening in Practice

When analyzing leveraged products like this, I frequently rely on the AI Screener to quickly filter for ETFs with similar leverage profiles or sector exposures. It helps surface technical setups and volatility patterns across thousands of names without manual effort, which keeps my research process efficient when evaluating tactical opportunities in small-cap or inverse strategies.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TZA

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


TZA's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for TZA moved out of overbought territory on October 02, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 instances where the indicator moved out of the overbought zone. In 26 of the 26 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 52 of 54 cases where TZA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for TZA turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 43 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TZA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

TZA broke above its upper Bollinger Band on September 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

TZA moved above its 50-day moving average on August 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TZA crossed bullishly above the 50-day moving average on September 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Following a +2.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where TZA advanced for three days, in 245 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 160 of 178 cases where TZA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the Russell 2000® Index. The fund invests at least 80% of its net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index measures the performance of approximately 2,000 small-cap companies in the Russell 3000® Index, based on a combination of their market capitalization and current index membership. It is non-diversified.
View a ticker or compare two or three
TZA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Inverse Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interact to see
Advertisement
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.
Shares of Iridium Communications (IRDM) surged approximately +11.00% in Thursday's session, rising from a prior close of $28.52 to an intraday high near $31.76. A broad-based equity market rally drove significant gains across communication and satellite sector stocks, as investor sentiment sharply reversed after days of macro-driven selling pressure tied to tariff fears.
AirSculpt Technologies, Inc. (AIRS) stands out as a leading provider of minimally invasive body contouring procedures through its Elite Body Sculpture brand. The company specializes in proprietary AirSculpt treatments that remove fat and tighten skin without general anesthesia. These include options like AirSculpt+, AirSculpt Smooth for cellulite reduction, and specialized fat transfer procedures such as Power BBL for Brazilian butt lifts, Up a Cup for breast enhancement, and Hip Flip for hourglass contouring. Based in Miami Beach, Florida, and founded in 2012, AIRS operates centers across the United States, Canada, and the United Kingdom.
ASRT stock surged +66% over the past 30 days, driven by strong Q4 2025 earnings beat and optimistic 2026 guidance highlighting Rolvedon growth. Over the past quarter, the stock rose +117%, fueled by improving gross margins, stable product demand, and analyst price target increases.
I've been following Advantage Solutions Inc. (ADV)closely as a key player in outsourced sales, marketing, merchandising, sampling, and retailer support services for consumer packaged goods (CPG) manufacturers and retailers across North America, Asia Pacific, and Europe. The company operates through three segments: Branded Services, Experiential Services, and Retailer Services. Its focus remains on optimizing in-store execution, boosting consumer engagement, and strengthening retail partnerships.
NCS Multistage Holdings, Inc. (NCSM) stands out as a leading provider of highly engineered products and support services that optimize oil and natural gas well construction, completions, and field development strategies. The company operates primarily in the United States, Canada, and internationally, with a focus on fracturing systems, enhanced oil recovery, well construction products, and tracer diagnostics.
MGNX stock surged +53% over the last 30 days, driven primarily by a positive Q4 earnings surprise and analyst upgrades. Over the past quarter, the stock rose +80%, reflecting recovery from early-year lows amid biotech sector volatility.
PENG shares are surging approximately +16% in today's session, trading around $20.42, up from a prior close of $17.60 The primary catalyst is a Q2 fiscal 2026 earnings beat, with non-GAAP EPS of $0.52 surpassing the consensus estimate of $0.43 — a ~21% upside earnings surprise.
TZA ETF Advances +21% as Small-Cap Weakness Persists